Drug Therapy

Citations 311-320 of 471 total displayed.

Past content (since Nov 1998):

Observations
Hair Depigmentation During Chemotherapy With a Class III/V Receptor Tyrosine Kinase Inhibitor

Shannon Routhouska; Anita C. Gilliam; Paradi Mirmirani
Arch Dermatol 2006; 142: 1477-1479. [Abstract] [Full text] [PDF]  

Editorials
Livedoid Vasculopathy: What It Is and How the Patient Should Be Evaluated and Treated

Jeffrey P. Callen
Arch Dermatol 2006; 142: 1481-1482. [Extract] [Full text] [PDF]  

Correspondence
Transdermal Therapy for Erythromelalgia

Jay S. Cohen
Arch Dermatol 2006; 142: 1508-a. [Extract] [Full text] [PDF]  

Correspondence
Leukocytoclastic Vasculitis Masquerading as Hand-Foot Syndrome in a Patient Treated With Sorafenib

Nancy M. Chung; Martin Gutierrez; Maria L. Turner
Arch Dermatol 2006; 142: 1510-1511. [Extract] [Full text] [PDF]  

Correspondence
Long-term Control of Papular Dermatitis ("Dermal Hypersensitivity Reaction") With Mycophenolate Mofetil

Scott L. Flugman
Arch Dermatol 2006; 142: 1512-1513. [Extract] [Full text] [PDF]  

Correspondence
Cytokine-Release Syndrome Related to Rituximab Limited to Lesions and Excision Scars of Lesions of Primary Cutaneous Lymphoma

Silvia Perez-Gala; Yolanda Delgado-Jimenez; Rebeca Goiriz; Javier Fraga; Amaro Garcia-Diez; Jesus Fernandez-Herrera
Arch Dermatol 2006; 142: 1516-1517. [Extract] [Full text] [PDF]  

Studies
Dermatologic Adverse Effects of Lenalidomide Therapy for Amyloidosis and Multiple Myeloma

Hans P. Sviggum; Mark D. P. Davis; S. Vincent Rajkumar; Angela Dispenzieri
Arch Dermatol 2006; 142: 1298-1302. [Abstract] [Full text] [PDF]  

Observations
Antimicrobial Allergy From Polyvinyl Chloride Gloves

Kristiina Aalto-Korte; Kristiina Alanko; Maj-Len Henriks-Eckerman; Riitta Jolanki
Arch Dermatol 2006; 142: 1326-1330. [Abstract] [Full text] [PDF]  

The Cutting Edge
Severe Hidradenitis Suppurativa Treated With Adalimumab

Danielle K. Moul; Neil J. Korman
Arch Dermatol 2006; 142: 1110-1112. [Extract] [Full text] [PDF]  

Studies
1% Pimecrolimus, 0.005% Calcipotriol, and 0.1% Betamethasone in the Treatment of Intertriginous Psoriasis: A Double-blind, Randomized Controlled Study

Alexander Kreuter; Anna Sommer; Julia Hyun; Matthias Bräutigam; Norbert H. Brockmeyer; Peter Altmeyer; Thilo Gambichler
Arch Dermatol 2006; 142: 1138-1143. [Abstract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48